Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB9181 - Provider product page
- Provider
- R&D Systems
- Product name
- Anti-Human MMP-14/MT1-MMP Monoclonal Antibody (Clone 128527)
- Antibody type
- Monoclonal
- Antigen
- Mouse myeloma cell line NS0-derived recombinant human MMP‑14/MT1‑MMP, Tyr112-Ala541 (predicted)
- Description
- Protein A or G purified from hybridoma culture supernatant
- Reactivity
- Human
- Host
- Mouse
- Antigen sequence
P50281
- Isotype
- IgG
- Vial size
- 500 µg
Submitted references Localization, Shedding, Regulation and Function of Aminopeptidase N/CD13 on Fibroblast like Synoviocytes.
Selective blockade of matrix metalloprotease-14 with a monoclonal antibody abrogates invasion, angiogenesis, and tumor growth in ovarian cancer.
Contractile forces contribute to increased glycosylphosphatidylinositol-anchored receptor CD24-facilitated cancer cell invasion.
Integrin α5β1 facilitates cancer cell invasion through enhanced contractile forces.
GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-meditated killing.
Morgan RL, Behbahani-Nejad N, Endres J, Amin MA, Lepore NJ, Du Y, Urquhart A, Chung KC, Fox DA
PloS one 2016;11(9):e0162008
PloS one 2016;11(9):e0162008
Selective blockade of matrix metalloprotease-14 with a monoclonal antibody abrogates invasion, angiogenesis, and tumor growth in ovarian cancer.
Kaimal R, Aljumaily R, Tressel SL, Pradhan RV, Covic L, Kuliopulos A, Zarwan C, Kim YB, Sharifi S, Agarwal A
Cancer research 2013 Apr 15;73(8):2457-2467
Cancer research 2013 Apr 15;73(8):2457-2467
Contractile forces contribute to increased glycosylphosphatidylinositol-anchored receptor CD24-facilitated cancer cell invasion.
Mierke CT, Bretz N, Altevogt P
The Journal of biological chemistry 2011 Oct 7;286(40):34858-71
The Journal of biological chemistry 2011 Oct 7;286(40):34858-71
Integrin α5β1 facilitates cancer cell invasion through enhanced contractile forces.
Mierke CT, Frey B, Fellner M, Herrmann M, Fabry B
Journal of cell science 2011 Feb 1;124(Pt 3):369-83
Journal of cell science 2011 Feb 1;124(Pt 3):369-83
GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-meditated killing.
Djafarzadeh R, Noessner E, Engelmann H, Schendel DJ, Notohamiprodjo M, von Luettichau I, Nelson PJ
Oncogene 2006 Mar 9;25(10):1496-508
Oncogene 2006 Mar 9;25(10):1496-508
No comments: Submit comment
No validations: Submit validation data